《中国原发性肝癌诊疗规范（2017年版）》
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition).
作者信息
Zhou Jian, Sun Hui-Chuan, Wang Zheng, Cong Wen-Ming, Wang Jian-Hua, Zeng Meng-Su, Yang Jia-Mei, Bie Ping, Liu Lian-Xin, Wen Tian-Fu, Han Guo-Hong, Wang Mao-Qiang, Liu Rui-Bao, Lu Li-Gong, Ren Zheng-Gang, Chen Min-Shan, Zeng Zhao-Chong, Liang Ping, Liang Chang-Hong, Chen Min, Yan Fu-Hua, Wang Wen-Ping, Ji Yuan, Cheng Wen-Wu, Dai Chao-Liu, Jia Wei-Dong, Li Ya-Ming, Li Ye-Xiong, Liang Jun, Liu Tian-Shu, Lv Guo-Yue, Mao Yi-Lei, Ren Wei-Xin, Shi Hong-Cheng, Wang Wen-Tao, Wang Xiao-Ying, Xing Bao-Cai, Xu Jian-Ming, Yang Jian-Yong, Yang Ye-Fa, Ye Sheng-Long, Yin Zheng-Yu, Zhang Bo-Heng, Zhang Shui-Jun, Zhou Wei-Ping, Zhu Ji-Ye, Liu Rong, Shi Ying-Hong, Xiao Yong-Sheng, Dai Zhi, Teng Gao-Jun, Cai Jian-Qiang, Wang Wei-Lin, Dong Jia-Hong, Li Qiang, Shen Feng, Qin Shu-Kui, Fan Jia
机构信息
Department of Liver Surgery & Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, Shanghai, China.
Department of Pathology, the Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
出版信息
Liver Cancer. 2018 Sep;7(3):235-260. doi: 10.1159/000488035. Epub 2018 Jun 14.
BACKGROUND
Hepatocellular carcinoma (HCC) (about 85-90% of primary liver cancer) is particularly prevalent in China because of the high prevalence of chronic hepatitis B infection. HCC is the fourth most common malignancy and the third leading cause of tumor-related deaths in China. It poses a significant threat to the life and health of Chinese people.
SUMMARY
This guideline presents official recommendations of the National Health and Family Planning Commission of the People's Republic of China on the surveillance, diagnosis, staging, and treatment of HCC occurring in China. The guideline was written by more than 50 experts in the field of HCC in China (including liver surgeons, medical oncologists, hepatologists, interventional radiologists, and diagnostic radiologists) on the basis of recent evidence and expert opinions, balance of benefits and harms, cost-benefit strategies, and other clinical considerations.
KEY MESSAGES
The guideline presents the Chinese staging system, and recommendations regarding patients with HCC in China to ensure optimum patient outcomes.
背景
肝细胞癌（HCC）（约占原发性肝癌的85 - 90%）在中国尤为常见，这是由于慢性乙型肝炎感染的高流行率所致。HCC是中国第四大常见恶性肿瘤，也是肿瘤相关死亡的第三大主要原因。它对中国人民的生命和健康构成了重大威胁。
总结
本指南提出了中华人民共和国国家卫生和计划生育委员会关于中国HCC的监测、诊断、分期及治疗的官方建议。该指南由中国HCC领域的50多名专家（包括肝脏外科医生、医学肿瘤学家、肝病学家、介入放射学家和诊断放射学家）根据最新证据、专家意见、利弊权衡、成本效益策略及其他临床考量编写而成。
关键信息
本指南介绍了中国分期系统以及针对中国HCC患者的建议，以确保患者获得最佳治疗效果。
Zotero 插件